SCHEMBL2494529

SCHEMBL2494529

OCCOC(c1ccccc1O)(c1ccccc1O)c1ccccc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
TDP1 Q9NUW8 3/20 0.43
TSHR P16473 2/20 0.43
IDO1 P14902 3/20 0.38
RECQL P46063 2/20 0.38
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
JAK2 O60674 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 2/20 0.35
CA2 P00918 2/20 0.35
NPC1 O15118 1/20 0.35
CA12 O43570 1/20 0.35
GMNN O75496 1/20 0.35
EGFR P00533 1/20 0.35
FYN P06241 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491938 0.89 KIF11 (0.46) ALDH1A1TDP1TSHRIDO1RECQL
SCHEMBL2492368 0.89 ALDH1A1 (0.41) ALDH1A1TDP1TSHRIDO1RECQL
SCHEMBL3149801 0.81 ALDH1A1 (0.50) ALDH1A1TDP1TSHRIDO1RECQL
SCHEMBL2492118 0.79 KIF11 (0.43) ALDH1A1TDP1TSHRRECQLLMNA
SCHEMBL2493496 0.78 KIF11 (0.37) ALDH1A1TDP1IDO1RECQLL3MBTL1
SCHEMBL2490811 0.78 ALDH1A1 (0.36) ALDH1A1TSHRRECQLGAAL3MBTL1
SCHEMBL2491593 0.76 CA1 (0.41) ALDH1A1TSHRLMNAGAAL3MBTL1
Di(Hydroxyethyl)Ether SCHEMBL9694545 0.73 ALDH1A1 (0.50) ALDH1A1TDP1TSHRIDO1RECQL
SCHEMBL11514536 0.73 TSHR (0.38) ALDH1A1TDP1TSHRIDO1RECQL
SCHEMBL2491921 0.72 KIF11 (0.63) ALDH1A1TDP1TSHRRECQLGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH ALDH1A1 1292/4885TDP1 2051/4885TSHR 100/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 ALDH1A1 1031/4885TDP1 2151/4885TSHR 75/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R ALDH1A1 1187/4885TDP1 2238/4885TSHR 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.